Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
15.23
+0.15 (0.99%)
Mar 30, 2026, 11:45 AM EDT - Market open
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $784.24 million as of March 30, 2026. Its market cap has increased by 70.82% in one year.
Market Cap
784.24M
Enterprise Value
504.06M
1-Year Change
70.82%
Ranking
Category
Stock Price
$15.23
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $784.24M, an increase of 5.88%. That is a compound annual growth rate of 0.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 776.50M | -18.10% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 815.69M |
| Janux Therapeutics | 801.76M |
| ARS Pharmaceuticals | 801.33M |
| Evommune | 798.89M |
| Aktis Oncology | 797.81M |
| SELLAS Life Sciences Group | 783.88M |
| Cullinan Therapeutics | 777.76M |
| SpyGlass Pharma | 753.31M |